166 related articles for article (PubMed ID: 36334154)
1. A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study.
Yilmaz NS; Sen B; Karadag RF; Aslan S; Ekmekci Ertek I; Bozkurt A; Cicek S; Bolu A; Ucar H; Kocak C; Cevik C; Bukan N
J Neural Transm (Vienna); 2022 Dec; 129(12):1513-1526. PubMed ID: 36334154
[TBL] [Abstract][Full Text] [Related]
2. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
[TBL] [Abstract][Full Text] [Related]
3. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.
Rothärmel M; Quesada P; Husson T; Harika-Germaneau G; Nathou C; Guehl J; Dalmont M; Opolczynski G; Miréa-Grivel I; Millet B; Gérardin E; Compère V; Dollfus S; Jaafari N; Bénichou J; Thill C; Guillin O; Moulier V
Psychol Med; 2023 Apr; 53(5):2060-2071. PubMed ID: 34579796
[TBL] [Abstract][Full Text] [Related]
4. The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: A pilot study.
Tateishi H; Setoyama D; Kang D; Matsushima J; Kojima R; Fujii Y; Mawatari S; Kikuchi J; Sakemura Y; Fukuchi J; Shiraishi T; Maekawa T; Kato TA; Asami T; Mizoguchi Y; Monji A
J Psychiatr Res; 2021 Jun; 138():194-199. PubMed ID: 33865168
[TBL] [Abstract][Full Text] [Related]
5. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
[TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
[TBL] [Abstract][Full Text] [Related]
7. Changes in the metabolites of cerebrospinal fluid induced by rTMS in treatment-resistant depression: A pilot study.
Tateishi H; Setoyama D; Kato TA; Kang D; Matsushima J; Nogami K; Mawatari S; Kojima R; Fujii Y; Sakemura Y; Shiraishi T; Imamura Y; Maekawa T; Asami T; Mizoguchi Y; Monji A
Psychiatry Res; 2022 Jul; 313():114636. PubMed ID: 35594657
[TBL] [Abstract][Full Text] [Related]
8. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
[TBL] [Abstract][Full Text] [Related]
11. Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis.
Meshkat S; Alnefeesi Y; Jawad MY; D Di Vincenzo J; B Rodrigues N; Ceban F; Mw Lui L; McIntyre RS; Rosenblat JD
Psychiatry Res; 2022 Nov; 317():114857. PubMed ID: 36194941
[TBL] [Abstract][Full Text] [Related]
12. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
[TBL] [Abstract][Full Text] [Related]
13. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
14. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation.
Brundin L; Sellgren CM; Lim CK; Grit J; Pålsson E; Landén M; Samuelsson M; Lundgren K; Brundin P; Fuchs D; Postolache TT; Traskman-Bendz L; Guillemin GJ; Erhardt S
Transl Psychiatry; 2016 Aug; 6(8):e865. PubMed ID: 27483383
[TBL] [Abstract][Full Text] [Related]
15. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression.
Cano M; Lee E; Polanco C; Barbour T; Ellard KK; Andreou B; Uribe S; Henry ME; Seiner S; Cardoner N; Soriano-Mas C; Camprodon JA
J Affect Disord; 2023 Jul; 333():140-146. PubMed ID: 37024015
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
17. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
[TBL] [Abstract][Full Text] [Related]
18. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
19. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.
Gedge L; Beaudoin A; Lazowski L; du Toit R; Jokic R; Milev R
Front Psychiatry; 2012; 3():12. PubMed ID: 22375129
[TBL] [Abstract][Full Text] [Related]
20. Central levels of tryptophan metabolites in subjects with bipolar disorder.
Trepci A; Sellgren CM; Pålsson E; Brundin L; Khanlarkhani N; Schwieler L; Landén M; Erhardt S
Eur Neuropsychopharmacol; 2021 Feb; 43():52-62. PubMed ID: 33339712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
